Breaking News Instant updates and real-time market news.

QSR

Restaurant Brands

$69.64

-0.655 (-0.93%)

, IWM

iShares Trust Russell 2000 Index Fund

$151.14

-0.95 (-0.62%)

08:45
06/26/19
06/26
08:45
06/26/19
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Restaurant Brands (QSR) 3.24% +2.93, iShares Russell 2000 Index ETF (IWM) 1.11% +0.30, Intrexon (XON) 38.47% +0.29, Rite Aid (RAD) 20.64% +0.19, KraneShares China Internet (KWEB) 1.42% +0.16, Zoom Video Communications (ZM) 3.74% +0.16, Direxion Junior Gold (JDST) 15.00% +0.11, Eldorado Resorts (ERI) 0.68% +0.07, Axovant Sciences (AXGT) 19.43% +0.05, and Office Depot (ODP) 0.33% +0.04.

QSR

Restaurant Brands

$69.64

-0.655 (-0.93%)

IWM

iShares Trust Russell 2000 Index Fund

$151.14

-0.95 (-0.62%)

XON

Intrexon

$7.34

0.17 (2.37%)

RAD

Rite Aid

$6.85

0.55 (8.73%)

ZM

Zoom Video

$84.88

-4.63 (-5.17%)

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$26.45

1.43 (5.72%)

ERI

Eldorado Resorts

$43.76

-2.1 (-4.58%)

AXGT

Axovant

$6.39

-0.04 (-0.62%)

ODP

Office Depot

$1.85

-0.045 (-2.38%)

  • 26

    Jun

  • 17

    Jul

QSR Restaurant Brands
$69.64

-0.655 (-0.93%)

06/25/19
FBCO
06/25/19
INITIATION
Target $78
FBCO
Outperform
Restaurant Brands initiated with an Outperform at Credit Suisse
Credit Suisse analyst Jerome Vinerier initiated Restaurant Brands with an Outperform and $78 price target.
06/11/19
EVER
06/11/19
INITIATION
EVER
Outperform
Restaurant Brands initiated with an Outperform at Evercore ISI
Evercore ISI analyst David Palmer started Restaurant Brands with an Outperform rating.
06/25/19
06/25/19
INITIATION
Target $78

Outperform
Credit Suisse bullish on Restaurant Brands, initiates with an Outperform
As previously reported, Credit Suisse analyst Lauren Silberman initiated Restaurant Brands with an Outperform and $78 price target. The analyst believes Restaurant Brands is well positioned to generate global market share gains across its portfolio with contribution from same-store sales and unit growth. Increased confidence in accelerating same-store sales and sustainable global unit growth across the portfolio should support multiple expansion near the high-end of heavily franchised peers, she contends.
05/30/19
CLVD
05/30/19
NO CHANGE
CLVD
Neutral
Restaurant Brands comps underperforming in Q2, says Cleveland Research
Cleveland Research analyst Steven Gojak said his checks indicate that Tim Hortons Canada comps appear to have slowed in May from the prior month and look to be running below consensus. Burger King U.S. comps also appear to be tracking below consensus according to his checks, Gojak said in a note to investors.
IWM iShares Trust Russell 2000 Index Fund
$151.14

-0.95 (-0.62%)

XON Intrexon
$7.34

0.17 (2.37%)

07/16/18
07/16/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Netflix (NFLX) downgraded to Underperform from Neutral at Buckingham with analyst Matthew Harrigan saying he estimates that the stock's current price implies "optimistic" views of the company reaching 360M global members in 2025 and 505M by 2033 along with a long-term operating profit margin near 35%. 2. Rockwell Automation (ROK) downgraded to Sell from Neutral at Goldman Sachs while Parker-Hannifin (PH) was downgraded to Neutral from Buy. 3. FedEx (FDX) downgraded to Neutral from Buy at UBS with analyst Thomas Wadewitz saying with a large global Express business representing 55% of revenue and about 13% of revenue linked to Asia, FedEx is exposed to risk from tariffs and potentially slower trade activity. 4. Hasbro (HAS) downgraded to Underperform from Market Perform at BMO Capital with analyst Gerrick Johnson saying the liquidation of Toys R US may be "more impactful than investors realize" after the initial 9% rally in the stock price on "relief that things were not worse," even as retailers are becoming more selective in the "pantry loading" inventory restocking process. 5. Intrexon (XON) downgraded to Underperform from Neutral at BofA/Merrill with analyst Derik de Bruin citing lack of near-term catalysts and lack of contribution from "advanced" programs until 2020s. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/18/19
JMPS
06/18/19
NO CHANGE
Target $14
JMPS
Outperform
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
After Intrexon and privately-held Surterra Wellness announced an exclusive licensing agreement to advance Surterra's cannabinoid production using Intrexon's proprietary yeast fermentation platform, JMP Securities analyst Jason N. Butler said he sees the pact as a positive for Intrexon that supports the value that can be generated across its platforms and sectors. He keeps an Outperform rating and $14 price target on Intrexon shares.
03/01/19
NORL
03/01/19
DOWNGRADE
Target $10
NORL
Market Perform
Intrexon downgraded to Market Perform from Outperform at Northland
Northland analyst Robert Breza downgraded Intrexon to Market Perform from Outperform after the company reported Q4 results and its auditors issued a going concern opinion. While management indicated that it is pursuing several strategic alternatives, he believes investors will take a wait and see attitude, Breza said. He lowered his price target on Intrexon shares to $10 from $17.
07/16/18
07/16/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Aptinyx (APTX) initiated with an Overweight at JPMorgan and an Outperform at BMO Capital as well as Aptinyx (APTX). 2. Magenta Therapeutics (MGTA) initiated with an Outperform at Wedbush, an Outperform at Cowen and JPMorgan, as well as a Buy at Goldman Sachs. 3. Wyndham Destinations (WYND) and Marriott Vacations (VAC) were initiated with a Buy at Jefferies while Hilton Grand Vacations (HGV) was initiated with a Hold. 4. AvroBio (AVRO) initiated with an Outperform at Wedbush, Cowen, and Wells Fargo, and an Overweight at Morgan Stanley. 5. Keurig Dr Pepper (KDP) resumed with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
RAD Rite Aid
$6.85

0.55 (8.73%)

04/17/19
GUGG
04/17/19
DOWNGRADE
GUGG
Sell
Rite Aid assumed with a Sell from Neutral at Guggenheim
04/18/19
04/18/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Morgan Stanley (MS) downgraded to Neutral from Buy at Citi with analyst Keith Horowitz saying Morgan Stanley reported "strong" Q1 results but the shares are fairly valued. 2. Snap (SNAP) downgraded to Negative from Mixed at Vertical Group and to Neutral from Outperform at Wedbush. 3. Rite Aid (RAD) downgraded with a Sell from Neutral at Guggenheim while Walgreens Boots Alliance (WBA) was downgraded with a Neutral from Buy. 4. CF Industries (CF) downgraded to Underperform from Buy at BofA/Merrill with analyst Steve Byrne saying he has spoken with 10 key channel contacts in the Cornbelt and several commented that never in their 30-plus year careers have they seen fertilizer applications this far behind, mainly due to the weather. 5. FMC Corporation (FMC) downgraded to Sector Perform from Outperform at RBC Capital with analyst Arun Viswanathan citing the "uncertainty of Rynaxypyr and Cyazypyr patent expiration" as well as the reduced multiple from the recent lithium separation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/25/19
DESJ
04/25/19
INITIATION
DESJ
Buy
Desjardins initiates HEXO Corp, Canopy Growth, Aurora Cannabis with a Buy
Desjardins analyst John Chu initiated HEXO Corp (HEXO), Canopy Growth (CGC), and Aurora Cannabis (ACB) with a Buy rating and respective price targets of C$14, C$74, and C$16.50 as part of a broad research note, saying the "hype" around legalization of adult-use cannabis in Canada remains strong in spite of "underwhelming" early months of sales. The analyst attributes the challenges to ramp-up, logistical and distribution issues, but expects investors to consider the opportunity as a "global" one. Chu believes that "major" consumer packaged goods companies like Constellation (STZ), InBev (BUD), and Altria (MO), as well as retailers like Walgreens (WBA), CVS (CVS), and Rite Aid (RAD) should "help push cannabis and hemp into the mainstream."
04/17/19
GUGG
04/17/19
DOWNGRADE
GUGG
Sell
Rite Aid assumed with a Sell from Neutral at Guggenheim
Guggenheim analyst Glen Santangelo assumed coverage of Rite Aid and downgraded the shares to Sell from the firm's Neutral rating under analyst John Heinbockel. Santangelo also lowered the price target fro Rite Aid to 35c per share, down from 45c per share. The analyst believes Rite Aid's "significant debt burden" and "high leverage will continue to limit Rite Aid's ability to work through its structural and competitive issues."
ZM Zoom Video
$84.88

-4.63 (-5.17%)

06/07/19
PIPR
06/07/19
NO CHANGE
Target $100
PIPR
Overweight
Zoom Video price target raised to $100 from $90 at Piper Jaffray
Piper Jaffray analyst Alex Zukin raised his price target for Zoom Video Communications to $100 from $90 saying the company last night posted a "strong" first quarter following its initial public offering. The analyst reiterates an Overweight rating on the shares.
06/07/19
FBCO
06/07/19
NO CHANGE
Target $90
FBCO
Neutral
Zoom Video price target raised to $90 from $80 at Credit Suisse
Credit Suisse analyst Brad Zelnick raised his price target for Zoom Video to $90 from $80, saying the company reported "exceptionally strong" results for its first quarter a public company with metrics that surpassed sell-side and buy-side expectations. He maintains a Neutral rating due to Zoom's premium valuation and embedded high expectations.
06/07/19
BOFA
06/07/19
NO CHANGE
Target $99
BOFA
Buy
Zoom Video price target raised to $99 from $89 at BofA/Merrill
BofA Merrill Lynch analyst Kash Rangan raised his price target on Zoom Video to $99 from $89 following the company's Q1 report, noting that both its revenues and billings beat his estimates. He increased his estimates "across the board" after the strong performance and keeps a Buy rating on Zoom Video shares.
06/18/19
06/18/19
INITIATION
Target $140

Buy
RingCentral initiated with a Buy at Needham
As previously reported, Needham analyst Richard Valera initiated RingCentral (RNG) with a Buy rating and a price target of $140, calling the company a "clear leader" in the Unified Communication as a Service, or UCaaS, market with the highest revenue and growth rate of any of its scale competitors. The analyst sees the company deriving benefits from the continued shift from premises-based communications to the cloud as well as RingCentral's "strong product and superior execution". Valera notes that he is monitoring the UCaaS competitive landscape with an eye on Zoom Video Communications (ZM) as a new competitor, but believes that RingCentral remains well positioned to grow its revenue and increase profitability.
JDST Direxion Daily Junior Gold Miners Index Bear 3x Shares
$26.45

1.43 (5.72%)

ERI Eldorado Resorts
$43.76

-2.1 (-4.58%)

06/25/19
MSCO
06/25/19
DOWNGRADE
Target $12.5
MSCO
Equal Weight
Caesars downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Thomas Allen downgraded Caesars (CZR) to Equal Weight from Overweight with a $12.50 price target after the company agreed to be acquired by Eldorado Resorts (ERI). While he sees a potential bull case to $15 per share where the market values Caesars at Friday's multiples inclusive of the greater than $500M of synergies expected for the merger, Allen said he also sees a less likely bear case of $9 per share if the deal were to fall apart.
06/25/19
WOLF
06/25/19
UPGRADE
WOLF
Outperform
Eldorado Resorts upgraded to Outperform from Peer Perform at Wolfe Research
Wolfe Research upgraded Eldorado Resorts (ERI) to Outperform from Peer Perform saying the acquisition of Caesars (CZR) is favorable in terms of deal synergies and resulting weakness has provided a buying opportunity.
06/25/19
NOMU
06/25/19
DOWNGRADE
NOMU
Neutral
Caesars downgraded to Neutral after takeover agreement at Nomura Instinet
As previously reported, Nomura Instinet analyst Harry Curtis downgraded Caesars (CZR) to Neutral from Buy after the company agreed to be acquired by Eldorado Resorts (ERI). After meeting with Eldorado's senior management to discuss the deal, his conclusion is that the team is talented and thorough, but more explaining will be needed to convince investors why now is the right time for such a transformational deal, Curtis added in a separate note about the buyer. He keeps a Neutral rating on Eldorado shares with a $42 price target on the stock.
06/25/19
RHCO
06/25/19
DOWNGRADE
Target $12.75
RHCO
Hold
Caesars downgraded to Hold from Buy at SunTrust
SunTrust analyst Barry Jonas downgraded Caesars (CZR) to Hold from Buy with a $12.75 price target following its agreement to be acquired by Eldorado Resorts (ERI). In a research note to investors, Jonas says he met with Eldorado CEO and CFO following the announcement, and says he left "positive" on the deal despite the share reaction, which he thinks was likely arb driven. Looking ahead, he says management appears "confident" in hitting their $500M synergy target with potentially meaningful upside.
AXGT Axovant
$6.39

-0.04 (-0.62%)

03/11/19
JMPS
03/11/19
NO CHANGE
Target $8
JMPS
Outperform
Axovant price target raised to $8 from $6 at JMP Securities
Following this morning's announcement of positive results from its AXO-Lenti-PD and AXO-AAV-GM2 programs, Axovant Sciences CEO provided additional color at a competitor conference which support the "compelling results," JMP Securities analyst Jason Butler tells investors in a research note. The analyst believes Axovant has assembled over the past 12 months a "differentiated and diversified" portfolio of gene therapy candidates. The AXO-Lenti-PD results demonstrated large improvements in motor function and reductions in dyskinesia, while the AXO-AAV-GM2 results showed a "clean" safety profile and demonstrated an "impressive" increase in Hex A enzyme activity, says Butler. He reiterates an Outperform rating on Axovant and raised his price target for the shares to $8 from $6. The stock in afternoon trading is up 31c, or 21%, to $1.79.
06/21/19
LEER
06/21/19
INITIATION
Target $18
LEER
Outperform
Axovant initiated with an Outperform at SVB Leerink
SVB Leerink initiated Axovant with an Outperform and $18 price target.
04/11/19
EVER
04/11/19
INITIATION
Target $3
EVER
Outperform
Axovant initiated with an Outperform at Evercore ISI
Evercore ISI analyst Ravi Mehrotra initiated Axovant with an Outperform rating and a price targets of $3. The analyst believes that the company's "pipeline of high-potential assets is not priced in to the stock", with the Street view on the company as a "GT asset collector with no platform premium". Mehrotra contends that Axovant's lead asset AXO-Lenti-PD offers "promising preclinical data" with about 5-times more potency than predecessor ProSavin.
06/06/19
JMPS
06/06/19
NO CHANGE
Target $28
JMPS
Outperform
Axovant price target raised to $28 after reverse split at JMP Securities
JMP Securities analyst Jason Butler raised his price target on Axovant shares to $28 from $8 to account for the stock's 1-for-8 reverse split and other share count changes. Additionally, he noted that he is enthused by the sustained improvements in OFF score that were reported at six months in the first cohort in the ongoing SUNRISE-PD Phase 2 trial in Parkinson's disease. Butler keeps an Outperform rating on Axovant shares, telling investors that today's updated results give him greater confidence in both the consistency and durability of benefits for AXO-Lenti-PD.
ODP Office Depot
$1.85

-0.045 (-2.38%)

05/09/19
05/09/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Market Perform from Outperform at BMO Capital with analyst Ambrish Srivastava saying semi stocks do not do well in a decelerating gross margin environment, particularly when the bottom in margin is around two years away. 2. Camping World (CWH) downgraded to Underperform from Neutral at BofA/Merrill with analyst John Lavallo stating the company's outlook for 2019 seems "optimistic" following the company's "challenging" Q1 results. 3. Office Depot (ODP) double downgraded to Underperform from Buy at BofA/Merrill with analyst Elizabeth Suzuki saying the company's Q1 report reduced her confidence in a near-term turnaround and she now believes Office Depot's guidance for the rest of the year may be too optimistic. 4. American Eagle (AEO) downgraded to Neutral from Outperform at Wedbush with analyst Jen Redding saying she believes that shares will continue to trade near 52-week lows for the foreseeable future. 5. Stamps.com (STMP) downgraded to Hold from Buy at Craig-Hallum with analyst George Sutton endorsing the company's long-term move to shift away from USPS exclusivity, but noting that it is a slower, more complicated process than he appreciated. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/09/19
BOFA
05/09/19
DOWNGRADE
Target $2
BOFA
Underperform
BofA/Merrill double downgrades Office Depot to Underperform after Q1 report
As previously reported, BofA Merrill Lynch analyst Elizabeth Suzuki double downgraded Office Depot to Underperform from Buy, stating that the company's Q1 report reduced her confidence in a near-term turnaround and she now believes Office Depot's guidance for the rest of the year may be too optimistic. Suzuki, who sees the stock struggling until the company shows consistent improvement in organic growth, cut her price target on Office Depot shares to $2 from $4.
05/09/19
BOFA
05/09/19
DOWNGRADE
Target $2
BOFA
Underperform
Office Depot downgraded to Underperform from Buy at BofA/Merrill
BofA/Merrill double downgraded Office Depot to Underperform from Buy and cut its price target for the shares to $2 from $4.
04/01/19
SBSH
04/01/19
UPGRADE
Target $18
SBSH
Neutral
Bed Bath & Beyond upgraded to Neutral from Sell at Citi
Citi analyst Geoff Small upgraded Bed Bath & Beyond (BBBY) to Neutral from Sell and raised his price target for the shares to $18 from $10 after taking over coverage of the name. Citi transferred coverage of Broadlines & Hardlines Retail names to Small. The analyst assumed coverage with Buy ratings on AutoZone (AZO), BJ's Wholesale (BJ), Home Depot (HD), Lowe's (LOW), O'Reilly Automotive (ORLY) and Walmart (WMT). The U.S. consumer remains on "solid footing" amid low unemployment, rising wages, declining gas prices, manageable levels of debt, and elevated consumer confidence, Small tells investors in a research note. However, he points out that we are in the ninth year of the current economic expansion and "the possibility of a macroeconomic slowdown cannot be ignored." The analyst prefers retailers operating in "defensive sectors that are less susceptible to disruption by online competitors," namely auto parts, broadlines and home improvement retail. Small also assumed Advance Auto Parts (AAP), Best Buy (BBY), Costco (COST) and Office Depot (ODP) with Neutral ratings.

TODAY'S FREE FLY STORIES

TCEHY

Tencent

$0.00

(0.00%)

, MDLA

Medallia

$37.09

(0.00%)

07:31
07/21/19
07/21
07:31
07/21/19
07:31
On The Fly
Opening Day: Start-up DouYou becomes China's biggest Wall Street IPO of 2019 »

Drugmaker Genmab raised…

TCEHY

Tencent

$0.00

(0.00%)

MDLA

Medallia

$37.09

(0.00%)

MIRM

Mirum Pharmaceuticals

$13.51

0.17 (1.27%)

FULC

Fulcrum Therapeutics

$12.49

-0.99 (-7.34%)

PHR

Phreesia

$24.01

-1.15 (-4.57%)

GMAB

Genmab

$18.06

-0.14 (-0.77%)

AMK

AssetMark Financial

$27.71

0.39 (1.43%)

ORCC

Owl Rock

$15.51

0.11 (0.71%)

DOYU

DouYu

$10.50

-0.51 (-4.63%)

NOVA

Sunnova Energy

$0.00

(0.00%)

CSTL

Castle Biosciences

$0.00

(0.00%)

WSG

Wanda Sports

$0.00

(0.00%)

LVGO

Livongo Health

$0.00

(0.00%)

HCAT

Health Catalyst

$0.00

(0.00%)

JNJ

Johnson & Johnson

$130.41

-1.62 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 22

    Jul

  • 23

    Jul

  • 23

    Jul

  • 24

    Jul

  • 24

    Jul

  • 31

    Jul

  • 14

    Aug

  • 09

    Sep

  • 16

    Sep

  • 15

    Oct

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

PYPL

PayPal

$118.65

-1.22 (-1.02%)

, V

Visa

$179.18

-1.34 (-0.74%)

08:31
07/20/19
07/20
08:31
07/20/19
08:31
Periodicals
MasterCard, Visa among best stocks to play fintech boom, Barron's says »

The fintech units within…

PYPL

PayPal

$118.65

-1.22 (-1.02%)

V

Visa

$179.18

-1.34 (-0.74%)

MA

MasterCard

$275.51

-1.11 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 24

    Jul

  • 30

    Jul

USB

U.S. Bancorp

$54.98

-0.2 (-0.36%)

, SBNY

Signature Bank

$123.87

1.07 (0.87%)

08:28
07/20/19
07/20
08:28
07/20/19
08:28
Periodicals
KeyCorp, U.S. Bancorp better positioned for Fed rate cut, Barron's says »

KeyCorp (KEY), Signature…

USB

U.S. Bancorp

$54.98

-0.2 (-0.36%)

SBNY

Signature Bank

$123.87

1.07 (0.87%)

KEY

KeyCorp

$17.45

0.15 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 29

    Aug

  • 16

    Oct

CMG

Chipotle

$746.80

-17.43 (-2.28%)

08:24
07/20/19
07/20
08:24
07/20/19
08:24
Periodicals
Chipotle stock made 'stunning' comeback, Barron's says »

Chipotle's stock is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 25

    Sep

BYND

Beyond Meat

$176.65

6.28 (3.69%)

07:40
07/20/19
07/20
07:40
07/20/19
07:40
Periodicals
Beyond Meat could spike after earnings, Barron's says »

After rising so…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

NFLX

Netflix

$315.10

-10.04 (-3.09%)

07:37
07/20/19
07/20
07:37
07/20/19
07:37
Periodicals
Netflix's problems have only just begun, Barron's says »

Netflix has a problem and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

, TGT

Target

$88.02

-0.48 (-0.54%)

07:34
07/20/19
07/20
07:34
07/20/19
07:34
Periodicals
Time to aim higher on Target's stock, Barron's says »

As retailers have…

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

TGT

Target

$88.02

-0.48 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 21

    Aug

  • 19

    Sep

  • 25

    Sep

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

, FDX

FedEx

$167.08

1.69 (1.02%)

07:31
07/20/19
07/20
07:31
07/20/19
07:31
Periodicals
FedEx ups game amid e-commerce growth, Barron's says »

It is time to embrace…

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

FDX

FedEx

$167.08

1.69 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 17

    Sep

  • 13

    Nov

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

, MSFT

Microsoft

$136.62

0.33 (0.24%)

07:27
07/20/19
07/20
07:27
07/20/19
07:27
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

MSFT

Microsoft

$136.62

0.33 (0.24%)

ORCL

Oracle

$57.55

-0.58 (-1.00%)

AZN

AstraZeneca

$40.11

-0.61 (-1.50%)

BMY

Bristol-Myers

$43.32

-0.72 (-1.63%)

LLY

Eli Lilly

$106.75

-1.57 (-1.45%)

GSK

GlaxoSmithKline

$40.97

-0.44 (-1.06%)

JNJ

Johnson & Johnson

$130.41

-1.62 (-1.23%)

MRK

Merck

$81.39

-1.28 (-1.55%)

NVS

Novartis

$93.58

-0.715 (-0.76%)

PFE

Pfizer

$42.78

-0.28 (-0.65%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$41.94

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 29

    Jul

  • 30

    Jul

  • 30

    Jul

  • 30

    Jul

  • 03

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 27

    Aug

  • 28

    Aug

  • 02

    Sep

  • 09

    Sep

  • 16

    Sep

  • 16

    Sep

  • 20

    Sep

  • 23

    Sep

  • 25

    Sep

  • 02

    Oct

  • 15

    Oct

  • 04

    Nov

BHVN

Biohaven Pharmaceutical

$44.16

-0.61 (-1.36%)

18:12
07/19/19
07/19
18:12
07/19/19
18:12
Hot Stocks
Biohaven receives CRL from FDA for application seeking NURTEC approval »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

CE

Celanese

$107.01

0.9 (0.85%)

18:01
07/19/19
07/19
18:01
07/19/19
18:01
Hot Stocks
Celanese announces acetyl intermediates price increases »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

F

Ford

$10.20

-0.06 (-0.58%)

17:48
07/19/19
07/19
17:48
07/19/19
17:48
Periodicals
Ford plans to lay off 185 employees at Ontario plant, Reuters reports »

A union local said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 23

    Oct

RTN

Raytheon

$178.55

2.45 (1.39%)

17:48
07/19/19
07/19
17:48
07/19/19
17:48
Hot Stocks
Raytheon awarded $191.01M Air Force contract modification »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

UTX

United Technologies

$132.37

1.08 (0.82%)

17:44
07/19/19
07/19
17:44
07/19/19
17:44
Hot Stocks
United Technologies awarded $253.71M Air Force contract »

United Technologies has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LMT

Lockheed Martin

$356.90

0.675 (0.19%)

17:40
07/19/19
07/19
17:40
07/19/19
17:40
Hot Stocks
Lockheed Martin awarded $1.47B Missile Defense Agency contract modification »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ARES

Ares Management

$28.13

-0.305 (-1.07%)

17:33
07/19/19
07/19
17:33
07/19/19
17:33
Syndicate
Breaking Syndicate news story on Ares Management »

Ares Management files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 06

    Aug

HAFC

Hanmi Financial

$21.68

-0.105 (-0.48%)

17:33
07/19/19
07/19
17:33
07/19/19
17:33
Hot Stocks
Hanmi Financial to delay release of Q2 results »

Hanmi Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

PAYS

Paysign

$17.49

-0.48 (-2.67%)

17:32
07/19/19
07/19
17:32
07/19/19
17:32
Syndicate
Breaking Syndicate news story on Paysign »

Paysign files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEOH

Methanex

$43.19

0.83 (1.96%)

17:28
07/19/19
07/19
17:28
07/19/19
17:28
Hot Stocks
Methanex reaches final investment decision on methanol plant in Geismar, LA »

Methanex Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

17:17
07/19/19
07/19
17:17
07/19/19
17:17
Conference/Events
Credit Suisse biotech analysts to hold an analyst/industry conference call »

Biotech Analysts provide…

17:14
07/19/19
07/19
17:14
07/19/19
17:14
Conference/Events
UBS retail/hardlines analyst to hold an analyst/industry conference call »

Retail/Hardlines Analyst…

SHIP

Seanergy Marine

$0.64

-0.0425 (-6.25%)

17:05
07/19/19
07/19
17:05
07/19/19
17:05
Hot Stocks
Seanergy Maritime receives noncompliance notice from Nasdaq »

Seanergy Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SONM

Sonim

$13.42

0.24 (1.82%)

16:41
07/19/19
07/19
16:41
07/19/19
16:41
Conference/Events
Sonim management to meet with Oppenheimer »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 26

    Jul

  • 12

    Sep

KINS

Kingstone Companies

$8.81

0.09 (1.03%)

16:30
07/19/19
07/19
16:30
07/19/19
16:30
Hot Stocks
Kingstone names Barry Goldstein CEO »

Kingstone Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 09

    Aug

16:30
07/19/19
07/19
16:30
07/19/19
16:30
Options
Preliminary option volume of 22.6M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.